Related Experiment Videos
Beta blockade in essential hypertension: an analysis of response to oxprenolol
Insights
Oxprenolol effectively lowers blood pressure in hypertensive patients, with doses above 160 mg showing no additional benefit. Predicting patient response to this beta blocker remains empirical due to a lack of clear influencing factors.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Essential hypertension is a common cardiovascular condition requiring effective management.
- Beta-blocking agents, such as oxprenolol, are frequently used in treating hypertension.
- Understanding drug efficacy and patient response is crucial for optimizing treatment strategies.
Purpose of the Study:
- To analyze the effects of oxprenolol on blood pressure and heart rate in patients with essential hypertension.
- To determine if higher doses of oxprenolol provide additional therapeutic benefits.
- To identify potential factors predicting patient response to oxprenolol treatment.
Main Methods:
- Retrospective analysis of data from 40 patients with essential hypertension.
- Patients were treated with oxprenolol monotherapy.
- Blood pressure and heart rate changes were monitored in relation to varying daily doses of oxprenolol.
Main Results:
- Blood pressure and heart rate reductions plateaued at daily doses exceeding 160 mg of oxprenolol.
- The observed fall in mean blood pressure ranged from 0 to 40 mmHg, with no distinct response groups.
- No significant correlation was found between blood pressure response and patient demographics, baseline heart rate, or drug-induced heart rate changes.
Conclusions:
- The use of oxprenolol in hypertension appears empirical, as predicting individual patient response is challenging.
- Higher oxprenolol doses beyond 160 mg daily do not yield further blood pressure reduction.
- The simplified effective dose range allows for rapid determination of oxprenolol's therapeutic effect.
Abstract:
The data from 40 patients with essential hypertension treated with oxprenolol alone have been used to analyse the falls of blood pressure and heart rate. Blood pressure and heart rate did not fall further as the daily dose was increased above 160 mg. The range of fall in mean pressure was from 0 to 40 mmHg and there was no clear separation into response groups. Pressure falls were unrelated to sex, age, initial heart rate, increase in heart rate on standing, the fall of heart rate with the drug, or the initial height of blood pressure. In the absence of predicting factors the use of oxprenolol, and, by deduction, other beta blocking agents, in hypertension remains empirical, but the simplification of the dose range allows the response to oxprenolol to be determined quickly.